Transcat, Inc. (NASDAQ:TRNS) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Transcat, Inc. (NASDAQ:TRNS) have earned a consensus rating of “Moderate Buy” from the five analysts that are presently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $130.25.

A number of equities research analysts have weighed in on the stock. StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. Northland Securities dropped their price target on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research report on Wednesday, October 30th. HC Wainwright reiterated a “buy” rating and set a $156.00 price target on shares of Transcat in a research report on Tuesday, October 29th. Oppenheimer reiterated an “outperform” rating and set a $130.00 price target (down from $155.00) on shares of Transcat in a research report on Wednesday, October 30th. Finally, Craig Hallum lifted their price target on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Conestoga Capital Advisors LLC boosted its stake in shares of Transcat by 17.9% in the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after purchasing an additional 137,830 shares during the period. Royce & Associates LP lifted its stake in Transcat by 8.2% in the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock worth $61,798,000 after acquiring an additional 38,774 shares during the last quarter. Champlain Investment Partners LLC lifted its stake in Transcat by 22.1% in the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after acquiring an additional 74,169 shares during the last quarter. Geode Capital Management LLC lifted its stake in Transcat by 5.4% in the third quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock worth $26,269,000 after acquiring an additional 11,106 shares during the last quarter. Finally, State Street Corp lifted its stake in Transcat by 8.1% in the third quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock worth $25,027,000 after acquiring an additional 15,514 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Trading Down 1.9 %

Transcat stock opened at $109.12 on Monday. Transcat has a 12-month low of $94.29 and a 12-month high of $147.12. The stock has a market cap of $1.00 billion, a P/E ratio of 55.11 and a beta of 0.70. The company has a 50-day moving average price of $111.36 and a 200 day moving average price of $119.31.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm had revenue of $67.83 million for the quarter, compared to analyst estimates of $70.30 million. During the same quarter in the previous year, the business posted $0.41 earnings per share. Transcat’s revenue for the quarter was up 8.0% on a year-over-year basis. As a group, analysts forecast that Transcat will post 1.76 EPS for the current year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.